International Clinical and Medical Case Reports Journal (ISSN: 2832-5788) | Volume 5, Issue 4 | Case Report | Open Access
Sagrika Shukla*
Lanka Mahesh1, Sagrika Shukla2*, Prateek Gupta3, Abhijeet Bhasin4, Sumit Dubey5 and Gaurav Mathpal6
1The Specialist Clinic Private practice, New Delhi, India
2Department of Periodontology and Implantology, SGT Dental College and Hospital, Haryana, India
3Department of Dentistry, Sanskaram University, Haryana, India
4Department of Periodontology and Implantology, Bhabha College of Dental Sciences, Bhopal, India
5Department of Prosthodontics, DJ Dental college and hospital, Modinagar, India
6Department of Prosthodontics, Panacea Clinic R, New Delhi, India
*Correspondence to: Sagrika Shukla
Fulltext PDFAim: To evaluate and compare bone regeneration in lateral sinus wall augmentation with indigenous hydroxyapatite and commercially available bovine hydroxyapatite graft in healthy subjects over a period of 6 months follow-up. Material and Method: 20 cases were enrolled for the study, 10 in each group, control group wherein, Bio-Oss® bone graft and 10 in test group where G-bone graft was placed respectively. Standard of Care (SOC) protocol was followed in performing sinus lift procedure. Followed by placed secured by tissue tags and sutures. 6 months post-operatively, bone core with trephine was obtained of size 3.2 mm for histological examination and implants were placed at the same surgical site. Bone core was then histologically evaluated for: new bone formation, Residual graft material, Particle size of new bone, Vascularity and Inflammation. Results: G-bone showed higher percentage for new bone formation, Residual graft material, Particle size of new bone, Vascularity and Inflammation at 6 months. Conclusion: G-bone is a useful substance for sinus augmentation.
Sinus augmentation, Bone graft, Bone formation, Xenograft, Hydroxyapatite.
Lanka Mahesh, Sagrika Shukla, Prateek Gupta, Abhijeet Bhasin, Sumit Dubey and Gaurav Mathpal. Comparative Evaluation of Bone Regeneration Using Synthetic Hydroxyapatite Versus Commercially Available Xenograft in Lateral Wall Sinus Augmentation: Non-Blinded, Randomized Controlled Trial. Int Clinc Med Case Rep Jour. 2026;5(4):1-10.